Current and historical daily PE Ratio for Ascendis Health Ltd (
JSE:ASC
) from 2013 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ascendis Health stock (JSE:ASC) PE ratio as of Jun 08 2024 is 6.29.
More Details
Ascendis Health Ltd (JSE:ASC) PE Ratio (TTM) Chart
Ascendis Health Ltd (JSE:ASC) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1267
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Ascendis Health PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 6.3 | 2024-03-12 | 6.5 |
| 2024-05-17 | 6.3 | 2024-03-11 | 6.4 |
| 2024-05-16 | 6.3 | 2024-03-08 | 6.5 |
| 2024-05-15 | 6.4 | 2024-03-07 | 6.4 |
| 2024-05-14 | 6.3 | 2024-03-06 | 6.4 |
| 2024-05-13 | 6.5 | 2024-03-05 | 6.4 |
| 2024-05-10 | 6.5 | 2024-03-04 | 6.4 |
| 2024-05-09 | 6.5 | 2024-03-01 | 6.4 |
| 2024-05-08 | 6.5 | 2024-02-29 | 6.4 |
| 2024-05-07 | 6.3 | 2024-02-28 | 6.4 |
| 2024-05-06 | 6.5 | 2024-02-27 | 6.4 |
| 2024-05-03 | 6.5 | 2024-02-26 | 6.5 |
| 2024-05-02 | 6.5 | 2024-02-23 | 6.4 |
| 2024-04-30 | 6.5 | 2024-02-22 | 6.4 |
| 2024-04-29 | 6.5 | 2024-02-21 | 6.4 |
| 2024-04-26 | 6.5 | 2024-02-20 | 6.5 |
| 2024-04-25 | 6.5 | 2024-02-19 | 6.4 |
| 2024-04-24 | 6.3 | 2024-02-16 | 6.5 |
| 2024-04-23 | 6.5 | 2024-02-15 | 6.4 |
| 2024-04-22 | 6.5 | 2024-02-14 | 6.4 |
| 2024-04-19 | 6.5 | 2024-02-13 | 6.4 |
| 2024-04-18 | 6.5 | 2024-02-12 | 6.4 |
| 2024-04-17 | 6.5 | 2024-02-09 | 6.5 |
| 2024-04-16 | 6.5 | 2024-02-08 | 6.5 |
| 2024-04-15 | 6.5 | 2024-02-07 | 6.5 |
| 2024-04-12 | 6.5 | 2024-02-06 | 6.5 |
| 2024-04-11 | 6.5 | 2024-02-05 | 6.4 |
| 2024-04-10 | 6.3 | 2024-02-02 | 6.5 |
| 2024-04-09 | 6.3 | 2024-02-01 | 6.5 |
| 2024-04-08 | 6.5 | 2024-01-31 | 6.4 |
| 2024-04-05 | 6.5 | 2024-01-30 | 6.5 |
| 2024-04-04 | 6.5 | 2024-01-29 | 6.4 |
| 2024-04-03 | 6.5 | 2024-01-26 | 6.4 |
| 2024-04-02 | 6.5 | 2024-01-25 | 6.4 |
| 2024-03-28 | 6.5 | 2024-01-24 | 6.5 |
| 2024-03-27 | 6.5 | 2024-01-23 | 6.4 |
| 2024-03-26 | 6.5 | 2024-01-22 | 6.4 |
| 2024-03-25 | 6.4 | 2024-01-19 | 6.5 |
| 2024-03-22 | 6.5 | 2024-01-18 | 6.4 |
| 2024-03-20 | 6.4 | 2024-01-17 | 6.5 |
| 2024-03-19 | 6.5 | 2024-01-16 | 6.5 |
| 2024-03-18 | 6.4 | 2024-01-15 | 6.4 |
| 2024-03-15 | 6.5 | 2024-01-12 | 6.5 |
| 2024-03-14 | 6.5 | 2024-01-11 | 6.4 |
| 2024-03-13 | 6.5 | 2024-01-10 | 6.3 |
Ascendis Health Ltd (JSE:ASC) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Ascendis Health Ltd
ISIN : ZAE000185005
Compare
Compare
Traded in other countries / regions
ASC.South Africa IPO Date
2013-11-22Description
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is theĀ contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers